On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

Drug maker GSK plc (GSK, GSK.L) confirmed Wednesday that it has reached two confidential settlements in cases filed in California ...

Zantac -- also known as ranitidine -- was a popular heartburn drug until 2020, when the Food and Drug Administration ordered it removed from pharmacy shelves because of a potential cancer risk. While ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

GSK announced on Wednesday that it has reached confidential settlements in two lawsuits filed in California State Court ...

A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported.

GSK plc (LSE/NYSE: GSK), a leading global pharmaceutical company, has reached a confidential settlement in a Zantac (ranitidine) related prostate cancer lawsuit filed by Mr. Isaac Dixon in ...

GSK plc (LSE/NYSE: LON:GSK), a leading global pharmaceutical company, has reached a confidential settlement in a Zantac (ranitidine) related prostate cancer lawsuit filed by Mr. Isaac Dixon in ...

Twelve days after GSK secured a key win in Florida, with a state court tossing expert testimony on the cancer-causing potential of heartburn drug Zantac (ranitidine), the British company has ...

(Alliance News) - GSK PLC on Wednesday said it reached two confidential settlements regarding the Zantac case in California State Court. The London-based pharmaceutical company said the cases ...